SUPERNEWS - NASDAQ:BIIB (Biogen Inc.) Stock Price, News, Quote, History

SUPERNEWS

Macro

Equities

Tech

Real Estate

Opinion

Analyst Insights

Top Movers

Crypto

Earnings

Equities

Top Stories

European Medicines Agency Rejects Leqembi, Biogen Shares Fall 5%

13 hours ago

Intraday: Tesla Defies Odds with 11% Surge, Biogen and Boston Up

Biogen (BIIB) and Boston Scientific (BSX) shares surged 4.1% and 6.1%, respectively, on strong earnings, while Enphase Energy (ENPH) and Old Dominion (ODFL) fell by 4.7% and 10% due to disappointing forecasts. Tesla's (TSLA) stock leaped by 11%, defying expectations with its Q1 results, highlighting the market's dynamic nature with significant movements across various sectors.

4/24, 14:09 EDT

Evercore ISI Optimistic on Biotech, Picks Top 5 Stocks for Growth

Evercore ISI optimistic on biotech's rebound with a 49% drop since 2021, highlighting five stocks for potential growth.

5/14, 11:49 EDT

Citi's Top Biotech Picks in $2.9B Market, Ionis Gets 50% Upside

Citi highlights three biotech stocks in a growing $2.9 billion hereditary angioedema market, with CSL's treatment poised for 50% upside.

4/30, 19:34 EDT

Pre-Market: Biotech Stocks Tumble on Trial Failures; Autodesk Climbs

Aerovate Therapeutics (AVTE) and Ovid Therapeutics (OVID) saw massive declines of 91% and 68% respectively, due to failed clinical trials, highlighting biotech sector risks. Autodesk (ADSK) rose 4.7% on Starboard Value's $500M stake, while Xponential Fitness (XPOF) surged 25% following the appointment of former Taco Bell CEO Mark King.

6/17, 10:36 EDT

European Medicines Agency Rejects Leqembi, Biogen Shares Fall 5%

13 hours ago

Intraday: Tesla Defies Odds with 11% Surge, Biogen and Boston Up

4/24, 14:09 EDT

Evercore ISI Optimistic on Biotech, Picks Top 5 Stocks for Growth

5/14, 11:49 EDT

BIIB News

Intraday: Fed Rate Cut Hopes Fuel 1.8% Dow Surge

9 hours ago

European Medicines Agency Rejects Leqembi, Biogen Shares Fall 5%

13 hours ago

Pre-Market: Futures Up as Investors Eye Inflation Data, Rate Cuts

16 hours ago

Beyond Novo and Eli Lilly: Fund Manager Highlights Amgen, Zealand, Viking in $130B Market

7/25, 19:32 EDT

Eli Lilly's Kisunla Gets US Nod, $32K for Alzheimer's Therapy

7/2, 15:45 EDT

Pre-Market: Biotech Stocks Tumble on Trial Failures; Autodesk Climbs

6/17, 10:36 EDT

Eli Lilly Alzheimer's Drug Wins FDA Panel Nod, Shares Up 1.8%

6/10, 17:35 EDT

Merck Buys EyeBio for $3bn, Boosts Eye Drug Pipeline

5/29, 02:45 EDT

Evercore ISI Optimistic on Biotech, Picks Top 5 Stocks for Growth

5/14, 11:49 EDT

Citi's Top Biotech Picks in $2.9B Market, Ionis Gets 50% Upside

4/30, 19:34 EDT

Intraday: Tesla Defies Odds with 11% Surge, Biogen and Boston Up

4/24, 14:09 EDT

Intraday: Tech and Finance Stocks Lead Market Surge, Despite Volatility

4/24, 10:44 EDT

Analysts Slash Targets on Tesla, Rivian Before Earnings

4/18, 02:17 EDT

US Pharmaceutical Companies Seek Alternative Suppliers Amid Proposed Legislation Targeting Chinese Biotech Firms

4/11, 00:06 EDT

Oversold Biogen & McDonald's Eye Rebound, Analysts Bullish

4/5, 13:52 EDT

Biotech Firms Aardvark and Viking Target Booming Anti-Obesity Drug Market

3/29, 07:25 EDT

Nvidia Leads Wall Street Picks with 82% Surge

3/27, 19:50 EDT

FDA Delays Decision on Eli Lilly's Alzheimer Drug Amid Safety Concerns

3/8, 09:36 EST

Pre-Market: Pre-Market Fluctuates Ahead of Critical Jobs Report

3/8, 08:31 EST

Pre-Market: Mixed Pre-Market Moves Signal Investor Wariness

3/8, 08:00 EST

Eli Lilly's Alzheimer's drug approval faces FDA delay, shares dip premarket

3/8, 07:43 EST

Florida Homeowners Brace for Insurance Premium Hikes Amid Climate Change Challenges

3/7, 15:48 EST

Nasdaq's Hidden Gems: Stocks with Over 20% Growth Potential

3/1, 14:38 EST

Stocks Surge and Plunge: Eli Lilly and Uber Overbought, Akamai and Biogen Oversold

2/16, 13:02 EST

Wall Street Sees Flurry of Activity with Upgrades and Downgrades Across Sectors

2/14, 08:41 EST

Analysts Initiate Coverage on First Solar and Palantir, Biogen Downgraded

2/14, 06:14 EST

[TOP MOVERS] Inflation Fears Spark Market Sell-Off, S&P Down 1.9%

2/13, 15:05 EST

[TOP MOVERS] Market Wary Ahead of Inflation Data, Sectors Show Strain

2/13, 08:54 EST

Biogen Reports Mixed Fourth-Quarter Results Amid Shift in Strategy

2/13, 07:34 EST

Citi Bullish on Chipotle, Sets $2,699 Target Ahead of Earnings

1/24, 08:38 EST

Wall Street Views

University College London

John Hardy, 7/26/24

Cautiously Optimistic on

BIIB

“The EMA decision will be revisited as US clinicians and others gather and report real-world experience.”

Cornell University

Costantino Iadecola, 6/10/24

Cautiously Optimistic on

BIIB

LLY

“If there are some subgroups where further analysis is required, this should not hold up making this drug available to the public.”

Mayo Foundation

Nilufer Ertekin-Taner, 6/10/24

Neutral on

BIIB

LLY

“More data was required for certain groups, including African Americans, Latin Americans and people with Down’s syndrome.”

Brian P. Skorney

Baird Analyst, 4/5/24

Bullish on

BIIB

MCD

“Optimism over Biogen’s potential expansion in Latin America, where the company can address roughly 2,000 to 4,000 patients for its spinal muscular atrophy treatment Spinraza.”